Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Adamson

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.
Journal of Pediatric Hematology/Oncology|February 10, 2004
Congenital neuroblastoma arising in the deltoid muscleTammy Kang, John Dormans, John Maris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Reply to N.-K.V. Cheung et alKatherine K Matthay, Wendy B London, John Maris, et al.
Pediatric Blood & Cancer|May 21, 2010
Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium studyStacey L Berg, Naomi Winick, Ashish Mark Ingle, et al.
Cancer|May 24, 2014
Declining childhood and adolescent cancer mortalityMalcolm A Smith, Sean F Altekruse, Peter C Adamson, et al.
Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperativesBarry D Anderson, Peter C Adamson, Susan L Weiner, et al.
Pediatric Blood & Cancer|August 3, 2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group reportJanet L Franklin, Nita L Seibel, Mark Krailo, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2011
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastomaRobin E Norris, Jane E Minturn, Garrett M Brodeur, et al.
Pediatric Blood & Cancer|July 29, 2009
A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group reportAnne L Angiolillo, Alice L Yu, Gregory Reaman, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Pediatric Blood & Cancer|February 24, 2015
The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology GroupElizabeth G Salazar, M Brooke Bernhardt, Yimei Li, et al.
Journal of Pediatric Hematology/Oncology|February 10, 2004
Congenital neuroblastoma arising in the deltoid muscleTammy Kang, John Dormans, John Maris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Reply to N.-K.V. Cheung et alKatherine K Matthay, Wendy B London, John Maris, et al.
Pediatric Blood & Cancer|May 21, 2010
Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium studyStacey L Berg, Naomi Winick, Ashish Mark Ingle, et al.
Cancer|May 24, 2014
Declining childhood and adolescent cancer mortalityMalcolm A Smith, Sean F Altekruse, Peter C Adamson, et al.
Pediatric Blood & Cancer|May 17, 2017
Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task ForceFrank M Balis, Richard B Womer, Stacey Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperativesBarry D Anderson, Peter C Adamson, Susan L Weiner, et al.
Pediatric Blood & Cancer|August 3, 2007
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group reportJanet L Franklin, Nita L Seibel, Mark Krailo, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2011
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastomaRobin E Norris, Jane E Minturn, Garrett M Brodeur, et al.
Pediatric Blood & Cancer|July 29, 2009
A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group reportAnne L Angiolillo, Alice L Yu, Gregory Reaman, et al.
Pageof 18